Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
By J. Pallesen, Nianshuang Wang, Kizzmekia S. Corbett, D. Wrapp, R. Kirchdoerfer, H. Turner, C. Cottrell, M. M. Becker, Lingshu Wang, Wei Shi and 8 more. 2017
1,071 citations recorded by the source corpus.
Subfields: Animal Science and Zoology, Infectious Diseases
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Animal Science and Zoology
In Infectious Diseases
Citations in the corpus
- Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation (2020, positive): “Finally, the introduction of double proline substitutions, herein 2P, to prevent fusogenic conformational changes of MERS-CoV S 20 and SARS-CoV S 55 was shown to stabilize the prefusion states of these glycoproteins.”
- The human coronavirus HCoV-229E S-protein structure and receptor binding (2019, methodology): “In addition, a dual-proline mutation (Thr871Pro/Ile872Pro) was 174 introduced to stabilize the pre-fusion form as previously described (36).”
- Adaptive immunity to SARS-CoV-2 and COVID-19 (2021, neutral): “, 2020) with trimer stabilization mutations (P-P) (Pallesen et al., 2017; Wrapp et al., 2020).”
- Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2 (2018, background): “Helix linker 2 is critical for the formation of the postfusion helix core, as has been shown in a previous study, which indicated that substitution of the residues in this region with prolines retains the S glycoprotein in the prefusion conformation and prevents conformational rearrangement [7] .”
- Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant (2020, neutral): “Models of coronavirus S-mediated membrane fusion describe ACE2 binding to all three RBD domains in the open conformation as destabilizing the pre-fusion S trimer, leading to dissociation of S1 from S2 and promoting transition to the post-fusion conformation (Pallesen et al., 2017; Walls et al., 2019”
- mRNA Vaccines in the COVID-19 Pandemic and Beyond. (2021, background): “Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.”
- SARS-CoV-2 Vaccines: Status Report (2020, background): “Unfortunately, older individuals typically respond less well to vaccination because of immune senescence (Sambhara and McElhaney, 2009).”